Fenbendazole 444 Mg For Human to Treat Cancer – Medzsupplier

  • Fenbendazole 444 Mg For Human to Treat Cancer – Medzsupplier

    Posted by james971 on August 15, 2024 at 10:03 am

    Common anthelmintic used in veterinary medicine, Fenbendazole 444 Mg has attracted interest for possible human cancer therapy action. Fenbendazole has been investigated for its capacity to stop cancer cell proliferation at 444 mg. Though mostly an anti-parasitic medicine, Fenbendazole targets a mechanism similarly used by several chemotherapy drugs: it disturbs microtubule synthesis, a step vital for cell division.

    Early research and anecdotal evidence point to Fenbendazole possibly interfering with glucose absorption in cancer cells, therefore depriving them of energy and causing cell death. Particularly among individuals searching for alternative cancer therapies, this off-label usage has attracted attention. Strong clinical studies are needed, nevertheless, and Fenbendazole is not licensed by authorities like the FDA for cancer therapy in people.

    Usually obtained from animal usage and adjusted for human use, the dose of 444 mg is usually split in cycles with breaks to reduce possible toxicity. This method has hazards even with its promise, including the possibility of adverse effects and the absence of uniform dosage. Anyone thinking about using Fenbendazole to treat cancer should see a medical practitioner and take it into account as part of a more comprehensive treatment course.

    james971 replied 1 month ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.